REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Vigilare Biopharma Private Limited (India)

Main Activities: Other Computer Related Services
Full name: Vigilare Biopharma Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Vigilare Biopharma Private Limited is an unlisted company, incorporated on 11/08/2014. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U72900TG2014PTC095220 and registration number is 095220. The company is a professional, scientific and technical company, it is engaged in other professional, scientific and technical activities.

Legal Address
Flat No.52,57, 1St Floor, Opp. Prerana Hospital Balaji Nagar, Kutakpally
Hyderabad; Telangana; Postal Code: 500072

Contact Details: Purchase the Vigilare Biopharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Vigilare Biopharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Vigilare Biopharma Private Limited report to view the information.
Registered Capital:
Purchase the Vigilare Biopharma Private Limited report to view the information.
Incorporation Date:
August 11, 2014
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Vigilare Biopharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
5.76%▲
Total operating revenue
6.04%▲
Operating profit (EBIT)
518.33%▲
EBITDA
186.54%▲
Net Profit (Loss) for the Period
829.71%▲
Total assets
0.46%▲
Total equity
18.65%▲
Operating Profit Margin (ROS)
6.26%▲
Net Profit Margin
6.64%▲
Return on Equity (ROE)
13.71%▲
Debt to Equity Ratio
-9.91%▼
Quick Ratio
0.28%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo